MedTrace Logo

The Effect of Taboo Game-Based Reinforcement on Medication Instruction

NCT07728110 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 111

Last updated 2026-07-27

No results posted yet for this study

Summary

Pharmacology courses are included in nursing curricula, and education on drug knowledge and drug administration is provided in basic nursing courses from the first year of education. However, research shows that students' knowledge of drugs is not at the desired level.

Today, in addition to classical methods, different methods are also used to evaluate information. Game-based approaches are frequently used in nursing for both learning and evaluating information. Escape rooms, digital games, simulation-based games, role-playing, puzzle games, and Kahoot are among the methods used in education . Studies have shown that when gamification is used in education and student evaluation, the recall of information is also at a better level.

This research aims to determine the effect of reinforcing nursing students' knowledge of frequently used medications in emergency departments with the Taboo game and the classic question-and-answer method on learning and information recall.

Conditions

  • No Medical Condition

Interventions

OTHER

Game

Using taboo game

OTHER

Question-and-answer method

Using the question-and-answer method as reinforcement.

Sponsors & Collaborators

  • Siirt University

    collaborator OTHER

  • Ankara Medipol University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-02
Primary Completion
2026-04-17
Completion
2026-06-17

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07728110 on ClinicalTrials.gov